CARMEL, Ind., Jan. 21, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und . Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NEURAXIS INC finden Sie auf Wallstreet Online.
After hours: March 4 at 5:05:02 p.m. EST ...
The financing will be used to advance Augmenta's AI-powered building design agents and tackle the construction industry's productivity and sustainability challenges ...
Malignant gliomas and medulloblastomas — the most common brain tumours affecting adults and children, respectively — remain responsible for a disproportionate level of morbidity and mortality ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback